All metabolic dysfunction–associated steatotic liver disease articles
-
NewsGut microbiota disruption predicts severe steatosis in MASLD patients
A new study links gut dysbiosis with severe steatosis in metabolic dysfunction–associated steatotic liver disease (MASLD). In a 61-patient cohort, those with the inflammation-linked Bact2 enterotype developed severe steatosis at lower thresholds.